AR060648A1 - Formas cristalinas de un compuesto de dimetilfenilo carbamoil etil piperidina - Google Patents
Formas cristalinas de un compuesto de dimetilfenilo carbamoil etil piperidinaInfo
- Publication number
- AR060648A1 AR060648A1 ARP070101778A ARP070101778A AR060648A1 AR 060648 A1 AR060648 A1 AR 060648A1 AR P070101778 A ARP070101778 A AR P070101778A AR P070101778 A ARP070101778 A AR P070101778A AR 060648 A1 AR060648 A1 AR 060648A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbamoil
- etil
- piperidine
- crystal forms
- dimethylene compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se refiere a formas de base libre cristalina de éster 1-[2-(4-{[(R)-2-(3-formilamino-4-hidroxifenil)-2-hidroxietilamino]metil}-2,5-dimetilfenilcarbamoil)etil]piperidin-4-ílico del ácido bifenil-2-ilcarbámico o a un solvato de las mismas. La presente también se refiere a composiciones farmacéuticas que contienen o se preparar a partir de dichas formas cristalinas; procesos e intermediarios utiles para preparar dichas formas cristalinas; y a métodos para usar dichas formas cristalinas, por ejemplo, para tratar un trastorno pulmonar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79470906P | 2006-04-25 | 2006-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060648A1 true AR060648A1 (es) | 2008-07-02 |
Family
ID=38556280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101778A AR060648A1 (es) | 2006-04-25 | 2007-04-24 | Formas cristalinas de un compuesto de dimetilfenilo carbamoil etil piperidina |
Country Status (10)
Country | Link |
---|---|
US (2) | US7880010B2 (es) |
EP (1) | EP2010490B1 (es) |
JP (1) | JP2009535340A (es) |
CN (1) | CN101426765A (es) |
AR (1) | AR060648A1 (es) |
AT (1) | ATE520660T1 (es) |
CA (1) | CA2650631A1 (es) |
PE (1) | PE20080195A1 (es) |
TW (1) | TW200811104A (es) |
WO (1) | WO2007127297A2 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals |
CN1758930B (zh) | 2003-03-27 | 2010-06-09 | 株式会社新日本科学 | 鼻腔用粉末药剂喷药装置 |
WO2006016530A1 (ja) * | 2004-08-10 | 2006-02-16 | Translational Research, Ltd. | 速効性でかつ高い吸収性を可能とする経鼻投与用組成物 |
EP1778626A1 (en) * | 2004-08-16 | 2007-05-02 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200811105A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
US20080071141A1 (en) * | 2006-09-18 | 2008-03-20 | Abhisuek Gattani | Method and apparatus for measuring attributes of an anatomical feature during a medical procedure |
JP5415769B2 (ja) | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
US20090216010A1 (en) * | 2008-02-22 | 2009-08-27 | Wei-Hong Tseng | Crystalline carbapenem compound and produced method thereof |
EP2419409B1 (en) * | 2009-04-14 | 2015-01-28 | Glaxo Group Limited | Process for the preparation of a biphenyl-2-ylcarbamic acid ester |
TR201903556T4 (tr) | 2009-04-23 | 2019-04-22 | Theravance Respiratory Co Llc | Muskarinik reseptör antagonisti ve beta 2 adrenerjik reseptör agonisti aktivitesine sahip diamid bileşikleri. |
EP2429495A4 (en) * | 2009-05-15 | 2014-01-22 | Shin Nippon Biomedical Lab Ltd | INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS |
US8827946B2 (en) | 2009-07-31 | 2014-09-09 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
AR083115A1 (es) | 2010-09-30 | 2013-01-30 | Theravance Inc | Sales oxalato cristalinas de un compuesto diamida |
EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
JP5877277B2 (ja) * | 2013-04-26 | 2016-03-02 | 富士フイルム株式会社 | 撮像装置及び画像表示方法 |
TW201704211A (zh) * | 2015-05-14 | 2017-02-01 | Sichuan Haisco Pharmaceutical Co Ltd | 具有β2受體激動及M受體拮抗活性的聯苯衍生物及其在醫藥上的用途 |
US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006635A1 (fr) | 1993-09-02 | 1995-03-09 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de carbamate et medicament le contenant |
WO1995021820A1 (fr) | 1994-02-10 | 1995-08-17 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive du carbamate et composition correspondante |
US6040344A (en) * | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
US6693202B1 (en) * | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
UA73965C2 (en) * | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
WO2003042160A1 (en) * | 2001-11-13 | 2003-05-22 | Theravance, Inc. | Aryl aniline beta-2 adrenergic receptor agonists |
TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
DE602004024383D1 (de) * | 2003-05-08 | 2010-01-14 | Theravance Inc | Kristalline formen eines arylanilin-beta-2-adrenergenrezeptor-agonists |
ES2329586T3 (es) * | 2003-11-21 | 2009-11-27 | Theravance, Inc. | Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino. |
EP1778626A1 (en) * | 2004-08-16 | 2007-05-02 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
WO2006023460A2 (en) * | 2004-08-16 | 2006-03-02 | Theravance, Inc. | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
US7558576B2 (en) * | 2005-03-29 | 2009-07-07 | Qualcomm Incorporated | Employing frequency offset to compensate for Doppler shift |
TW200811105A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
-
2007
- 2007-04-23 TW TW096114174A patent/TW200811104A/zh unknown
- 2007-04-24 CN CNA2007800142180A patent/CN101426765A/zh active Pending
- 2007-04-24 WO PCT/US2007/010120 patent/WO2007127297A2/en active Application Filing
- 2007-04-24 AR ARP070101778A patent/AR060648A1/es unknown
- 2007-04-24 US US11/789,154 patent/US7880010B2/en not_active Expired - Fee Related
- 2007-04-24 CA CA002650631A patent/CA2650631A1/en not_active Abandoned
- 2007-04-24 JP JP2009507797A patent/JP2009535340A/ja active Pending
- 2007-04-24 EP EP07794375A patent/EP2010490B1/en active Active
- 2007-04-24 AT AT07794375T patent/ATE520660T1/de not_active IP Right Cessation
- 2007-04-24 PE PE2007000508A patent/PE20080195A1/es not_active Application Discontinuation
-
2010
- 2010-12-16 US US12/970,013 patent/US20110086881A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2010490B1 (en) | 2011-08-17 |
EP2010490A2 (en) | 2009-01-07 |
US20110086881A1 (en) | 2011-04-14 |
ATE520660T1 (de) | 2011-09-15 |
PE20080195A1 (es) | 2008-04-04 |
US20070249674A1 (en) | 2007-10-25 |
US7880010B2 (en) | 2011-02-01 |
WO2007127297A3 (en) | 2007-12-21 |
CA2650631A1 (en) | 2007-11-08 |
CN101426765A (zh) | 2009-05-06 |
WO2007127297A2 (en) | 2007-11-08 |
TW200811104A (en) | 2008-03-01 |
JP2009535340A (ja) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR060648A1 (es) | Formas cristalinas de un compuesto de dimetilfenilo carbamoil etil piperidina | |
AR051003A1 (es) | Forma cristalina de un compuesto bifenilo | |
AR106744A2 (es) | Formas cristalinas de un compuesto de bifenilo | |
PE20110810A1 (es) | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 | |
TW200800948A (en) | Novel compound | |
EA201390481A1 (ru) | Кристаллические оксалатные соли диамидного соединения | |
AR061926A1 (es) | Compuestos de piperidina, utiles como inhibidores de la proteina de transfe-rencia de esteres de colesterol, composicion farmaceutica y uso | |
ITMI20050912A1 (it) | Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici | |
BR112013011580A2 (pt) | derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep | |
DK2021337T3 (da) | Inhibitorer af 11-beta-hydroxysteroid-dehydrogenase-1 | |
ATE472542T1 (de) | 11-beta-hydroxysteroid-dehydrogenase-1-hemmer | |
SG10201407913UA (en) | Crystalline freebase forms of a biphenyl compound | |
BR112013000877A2 (pt) | processo para a preparação de um ácido bifenil-2-il carbâmico | |
CO6361988A2 (es) | Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)fenil]piperidina. | |
BRPI0712889A8 (pt) | composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica. | |
BR112013005434A2 (pt) | novo mono-hidrato de derivados de aza-adamantano | |
EA200900985A1 (ru) | Способ получения оптически чистого омепразола | |
CO6390054A2 (es) | Formas cristalinas de un compuesto 3-carboxipropil-aminotetralina | |
CY1112979T1 (el) | Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου | |
ATE546451T1 (de) | Cyclopropancarbonsäureester von acyclovir | |
CY1117075T1 (el) | Κρυσταλλικη ελευθερη βαση σε μορφη μιας διφαινυλικης ενωσης | |
ECSP099383A (es) | Derivado piperidínico utilizado para tratar enfermedades mediadas por el receptor 5 de quimiocina | |
TH110694A (th) | เตตระไฮโดรซินโนลีนในฐานะตัวยับยั้ง 11 เบต้า hsd1 สำหรับโรคเบาหวาน | |
TH110694B (th) | เตตระไฮโดรซินโนลีนในฐานะตัวยับยั้ง 11 เบต้า hsd1 สำหรับโรคเบาหวาน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |